Erelzi 25Mg. 50Mg 25mg. 50mg Solution for injection
PDF Leaflet Revision Date: 24 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various autoimmune conditions including rheumatoid arthritis and plaque psoriasis.
Dosage (summary)
Adults: 25 mg twice weekly or 50 mg once weekly. Children: 0.4 mg/kg (max 25 mg) twice weekly or 0.8 mg/kg (max 50 mg) once weekly.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if clearly needed; crosses placenta and excreted in breast milk.
Key Drug Interactions
- Anakinra
- Abatacept
- Sulfasalazine
Contraindications
- Hypersensitivity to etanercept
- Active infections
- Sepsis
Common side effects
- Injection site reactions
- Infections
- Headache
- Allergic reactions
Counselling Points
- Monitor for signs of infection
- Avoid live vaccines
- Report any allergic reactions
Serious warnings
- Serious infections including tuberculosis
- Malignancies
- Autoimmune disorders
Important Disclaimer
The Erelzi 25Mg. 50Mg 25mg. 50mg Solution for injection professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
